These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
751 related articles for article (PubMed ID: 33359245)
1. MicroRNA -383-5p restrains the proliferation and migration of breast cancer cells and promotes apoptosis via inhibition of PD-L1. Azarbarzin S; Hosseinpour-Feizi MA; Banan Khojasteh SM; Baradaran B; Safaralizadeh R Life Sci; 2021 Feb; 267():118939. PubMed ID: 33359245 [TBL] [Abstract][Full Text] [Related]
2. Tumor suppressive activity of miR-424-5p in breast cancer cells through targeting PD-L1 and modulating PTEN/PI3K/AKT/mTOR signaling pathway. Dastmalchi N; Hosseinpourfeizi MA; Khojasteh SMB; Baradaran B; Safaralizadeh R Life Sci; 2020 Oct; 259():118239. PubMed ID: 32784058 [TBL] [Abstract][Full Text] [Related]
3. MiRNA-138-5p: A strong tumor suppressor targeting PD-L-1 inhibits proliferation and motility of breast cancer cells and induces apoptosis. Rasoolnezhad M; Safaralizadeh R; Hosseinpourfeizi MA; Banan-Khojasteh SM; Baradaran B Eur J Pharmacol; 2021 Apr; 896():173933. PubMed ID: 33545160 [TBL] [Abstract][Full Text] [Related]
4. The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer. Dastmalchi N; Azarbarzin S; Safaralizadeh R; Khojasteh SMB; Shadbad MA; Amini M; Baghbanzadeh A; Asl ER; Baghbani E; Lotfinejad P; Baradaran B Med Oncol; 2021 Nov; 39(1):9. PubMed ID: 34761351 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of hsa-miR-570-3p targeting CD274 on triple negative breast cancer by blocking PI3K/AKT/mTOR signaling pathway. Wang LL; Huang WW; Huang J; Huang RF; Li NN; Hong Y; Chen ML; Wu F; Liu J Kaohsiung J Med Sci; 2020 Aug; 36(8):581-591. PubMed ID: 32311203 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-424-5p enhances chemosensitivity of breast cancer cells to Taxol and regulates cell cycle, apoptosis, and proliferation. Dastmalchi N; Safaralizadeh R; Hosseinpourfeizi MA; Baradaran B; Khojasteh SMB Mol Biol Rep; 2021 Feb; 48(2):1345-1357. PubMed ID: 33555529 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-218-5p inhibit the migration and proliferation of pterygium epithelial cells by targeting EGFR via PI3K/Akt/mTOR signaling pathway. Han S; Chen Y; Gao Y; Sun B; Kong Y Exp Eye Res; 2019 Jan; 178():37-45. PubMed ID: 30243568 [TBL] [Abstract][Full Text] [Related]
8. Mechanism of miR-122-5p regulating the activation of PI3K-Akt-mTOR signaling pathway on the cell proliferation and apoptosis of osteosarcoma cells through targeting TP53 gene. Li KW; Wang SH; Wei X; Hou YZ; Li ZH Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12655-12666. PubMed ID: 33378012 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-493-5p inhibits proliferation and metastasis of osteosarcoma cells by targeting Kruppel-like factor 5. Zhang Z; Luo G; Yu C; Yu G; Jiang R; Shi X J Cell Physiol; 2019 Aug; 234(8):13525-13533. PubMed ID: 30773645 [TBL] [Abstract][Full Text] [Related]
10. MiR-155-5p exerts tumor-suppressing functions in Wilms tumor by targeting IGF2 via the PI3K signaling pathway. Luo X; Dong J; He X; Shen L; Long C; Liu F; Liu X; Lin T; He D; Wei G Biomed Pharmacother; 2020 May; 125():109880. PubMed ID: 32004974 [TBL] [Abstract][Full Text] [Related]
11. miR-215-5p is an anticancer gene in multiple myeloma by targeting RUNX1 and deactivating the PI3K/AKT/mTOR pathway. Liu S; Zhang Y; Huang C; Lin S J Cell Biochem; 2020 Feb; 121(2):1475-1490. PubMed ID: 31498483 [TBL] [Abstract][Full Text] [Related]
12. MiR-873/PD-L1 axis regulates the stemness of breast cancer cells. Gao L; Guo Q; Li X; Yang X; Ni H; Wang T; Zhao Q; Liu H; Xing Y; Xi T; Zheng L EBioMedicine; 2019 Mar; 41():395-407. PubMed ID: 30803931 [TBL] [Abstract][Full Text] [Related]
13. microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2. Teng P; Jiao Y; Hao M; Tang X J Cell Biochem; 2018 Jul; 119(7):5243-5252. PubMed ID: 29236322 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-99b suppresses human cervical cancer cell activity by inhibiting the PI3K/AKT/mTOR signaling pathway. Li YJ; Wang Y; Wang YY J Cell Physiol; 2019 Jun; 234(6):9577-9591. PubMed ID: 30480801 [TBL] [Abstract][Full Text] [Related]
15. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation. Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of miR-361-5p in triple-negative breast cancer (TNBC) inhibits migration and invasion by targeting RQCD1 and inhibiting the EGFR/PI3K/Akt pathway. Han J; Yu J; Dai Y; Li J; Guo M; Song J; Zhou X Bosn J Basic Med Sci; 2019 Feb; 19(1):52-59. PubMed ID: 29924958 [TBL] [Abstract][Full Text] [Related]
17. microRNA-20b-5p overexpression combing Pembrolizumab potentiates cancer cells to radiation therapy via repressing programmed death-ligand 1. Jiang K; Zou H Bioengineered; 2022 Jan; 13(1):917-929. PubMed ID: 34968160 [TBL] [Abstract][Full Text] [Related]
18. miR-34a and miR-125a-5p inhibit proliferation and metastasis but induce apoptosis in hepatocellular carcinoma cells via repressing the MACC1-mediated PI3K/AKT/mTOR pathway. Zhang YM; Wu QM; Chang LY; Liu JC Neoplasma; 2020 Sep; 67(5):1042-1053. PubMed ID: 32484698 [TBL] [Abstract][Full Text] [Related]
19. A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery. Shadbad MA; Safaei S; Brunetti O; Derakhshani A; Lotfinejad P; Mokhtarzadeh A; Hemmat N; Racanelli V; Solimando AG; Argentiero A; Silvestris N; Baradaran B Genes (Basel); 2021 Aug; 12(8):. PubMed ID: 34440380 [TBL] [Abstract][Full Text] [Related]
20. The depletion of Circ-PRKDC enhances autophagy and apoptosis in T-cell acute lymphoblastic leukemia via microRNA-653-5p/Reelin mediation of the PI3K/AKT/mTOR signaling pathway. Ling Z; Fang ZG; Wu JY; Liu JJ Kaohsiung J Med Sci; 2021 May; 37(5):392-401. PubMed ID: 33615686 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]